CA3190997A1 - Hybrid amide derivatives of amphotericin b - Google Patents
Hybrid amide derivatives of amphotericin bInfo
- Publication number
- CA3190997A1 CA3190997A1 CA3190997A CA3190997A CA3190997A1 CA 3190997 A1 CA3190997 A1 CA 3190997A1 CA 3190997 A CA3190997 A CA 3190997A CA 3190997 A CA3190997 A CA 3190997A CA 3190997 A1 CA3190997 A1 CA 3190997A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- amb
- compounds
- acid
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063063655P | 2020-08-10 | 2020-08-10 | |
| US63/063,655 | 2020-08-10 | ||
| US202163175771P | 2021-04-16 | 2021-04-16 | |
| US63/175,771 | 2021-04-16 | ||
| PCT/US2021/045205 WO2022035752A1 (en) | 2020-08-10 | 2021-08-09 | Hybrid amide derivatives of amphotericin b |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3190997A1 true CA3190997A1 (en) | 2022-02-17 |
Family
ID=80247344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3190997A Pending CA3190997A1 (en) | 2020-08-10 | 2021-08-09 | Hybrid amide derivatives of amphotericin b |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230357303A1 (https=) |
| EP (2) | EP4696379A3 (https=) |
| JP (1) | JP7656359B2 (https=) |
| KR (1) | KR20230061405A (https=) |
| CN (1) | CN116323632B (https=) |
| AU (1) | AU2021325676A1 (https=) |
| CA (1) | CA3190997A1 (https=) |
| ES (1) | ES3061451T3 (https=) |
| IL (1) | IL300441A (https=) |
| MX (1) | MX2023001649A (https=) |
| PT (1) | PT4192248T (https=) |
| WO (1) | WO2022035752A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL122086B1 (en) * | 1979-04-09 | 1982-06-30 | Politechnika Gdanska | Process for preparing amides of antibiotics from the group of polyene macrolides and their derivativesvykh makrolidov i ikh proizvodnykh |
| AU643141B2 (en) | 1991-03-15 | 1993-11-04 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| US6664241B2 (en) * | 2000-05-31 | 2003-12-16 | Micrologix Biotech Inc. | Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof |
| JP6543272B2 (ja) * | 2014-05-16 | 2019-07-10 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ | 低減された毒性を有するアンホテリシンｂ誘導体 |
| TWI702223B (zh) * | 2014-06-12 | 2020-08-21 | 日商塩野義製藥股份有限公司 | 多烯巨環內酯衍生物 |
| CA3021061C (en) * | 2015-04-15 | 2023-10-24 | Martin D. Burke | Derivatives of amphotericin b |
| JP7477177B2 (ja) * | 2018-09-07 | 2024-05-01 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ | 毒性が低減されたハイブリッドアムホテリシンｂ誘導体 |
| EP4009985A4 (en) * | 2019-08-08 | 2023-09-06 | The Board Of Trustees Of The University Of Illinois | HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B |
-
2021
- 2021-08-09 US US18/020,119 patent/US20230357303A1/en active Pending
- 2021-08-09 CA CA3190997A patent/CA3190997A1/en active Pending
- 2021-08-09 IL IL300441A patent/IL300441A/en unknown
- 2021-08-09 ES ES21856507T patent/ES3061451T3/es active Active
- 2021-08-09 EP EP25211492.1A patent/EP4696379A3/en active Pending
- 2021-08-09 MX MX2023001649A patent/MX2023001649A/es unknown
- 2021-08-09 KR KR1020237008208A patent/KR20230061405A/ko active Pending
- 2021-08-09 EP EP21856507.5A patent/EP4192248B1/en active Active
- 2021-08-09 PT PT218565075T patent/PT4192248T/pt unknown
- 2021-08-09 JP JP2023508551A patent/JP7656359B2/ja active Active
- 2021-08-09 AU AU2021325676A patent/AU2021325676A1/en active Pending
- 2021-08-09 CN CN202180066848.2A patent/CN116323632B/zh active Active
- 2021-08-09 WO PCT/US2021/045205 patent/WO2022035752A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES3061451T3 (en) | 2026-04-01 |
| JP2023537921A (ja) | 2023-09-06 |
| EP4192248B1 (en) | 2025-12-03 |
| JP7656359B2 (ja) | 2025-04-03 |
| IL300441A (en) | 2023-04-01 |
| WO2022035752A1 (en) | 2022-02-17 |
| EP4696379A3 (en) | 2026-02-25 |
| EP4192248A1 (en) | 2023-06-14 |
| CN116323632B (zh) | 2024-12-31 |
| EP4192248A4 (en) | 2024-12-04 |
| AU2021325676A1 (en) | 2023-03-30 |
| MX2023001649A (es) | 2023-04-24 |
| US20230357303A1 (en) | 2023-11-09 |
| KR20230061405A (ko) | 2023-05-08 |
| CN116323632A (zh) | 2023-06-23 |
| EP4696379A2 (en) | 2026-02-18 |
| PT4192248T (pt) | 2026-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7469862B2 (ja) | 治療指数が改善されたアンフォテリシンｂ誘導体 | |
| JP2001010953A (ja) | ２，４−ジスルホフェニルブチルニトロン、その塩および薬学的スピントラップ剤としてのそれらの使用 | |
| AU2012254093B2 (en) | Effective amounts of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo(2,3-b)indol-5-yl phenylcarbamate and methods thereof | |
| US11198705B2 (en) | Hybrid Amphotericin B derivatives with reduced toxicity | |
| CA3190997A1 (en) | Hybrid amide derivatives of amphotericin b | |
| AU2020329149A1 (en) | Combination treatment of systemic fungal infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240802 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240802 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250801 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250801 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250806 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250820 |